3d-ssp analysis for amyloid brain pet imaging using¹⁸f-florbetapir in patients with alzheimer’s dementia and mild cognitive impairment

by Tanyaluck Thientunyakit, Chakmeedaj Sethanandha, Weerasak Muangpaisan, Satoshi Minoshima
Published 2022

Utility of adding SPECT/CT imaging to post-therapeutic radioiodine whole-body scan in patients with differentiated thyroid cancer

by Jiraporn Sriprapaporn, Chakmeedaj Sethanandha, Tawee Yingsa-Nga, Chulaluk Komoltri, Thonnapong Thongpraparn, Chompunoot Harnnanthawiwat
Published 2018

Relationship between F-18 florbetapir uptake in occipital lobe and neurocognitive performance in Alzheimer’s disease

by Tanyaluck Thientunyakit, Thonnapong Thongpraparn, Chakmeedaj Sethanandha, Takahiro Yamada, Yuichi Kimura, Weerasak Muangpaisan, Kazunari Ishii
Published 2022

Implementation of [ 18 F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: First-hand experience in Thailand

by Tanyaluck Thientunyakit, Chakmeedaj Sethanandha, Weerasak Muangpaisan, Orasa Chawalparit, Kuntarat Arunrungvichian, Tossaporn Siriprapa, Thonnapong Thongpraparn, Rujaporn Chanachai, Juri Gelovani
Published 2019

Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a ran...

by Nare Torosyan, Chakmeedaj Sethanandha, Joshua D. Grill, Michelle L. Dilley, Jooyeon Lee, Jeffrey L. Cummings, Celine Ossinalde, Daniel H. Silverman
Published 2019

Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer’s disease

by Tanyaluck Thientunyakit, Chakmeedaj Sethanandha, Weerasak Muangpaisan, Orasa Chawalparit, Kuntarat Arunrungvichian, Tossaporn Siriprapa, Yudthaphon Vichianin, Swatabdi Kamal, Chaiyawat Suppasilp, Thonnapong Thongpraparn, Rujaporn Chanachai, Juri G. Gelovani
Published 2020